Skip to content

Serum Free Light Chain Immunoassay (kappa and lambda)

Published: August 9, 2026Updated: August 16, 2026

This test measures the free kappa and lambda light chains in your blood, which are small protein fragments produced by plasma cells. It helps identify conditions affecting plasma cells, such as multiple myeloma or other monoclonal gammopathies.

Quick summary

["This test helps diagnose and monitor certain blood disorders linked to abnormal protein production."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
108865-7
Short code
RF IgM Msmt Ser
Synonyms
RF IgM Msmt Ser
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
86430
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your healthcare provider may order this test if you have symptoms like unexplained fatigue, frequent infections, or unexplained bone pain. It may also be used to monitor treatment progress in people with known plasma cell disorders or to screen for conditions like multiple myeloma or Waldenström macroglobulinemia.

What to Expect Before the Test

No special preparation is needed. You may have a small needle inserted into a vein in your arm to draw blood. This usually takes a few minutes and is generally not painful. Avoid eating or drinking for a short time before the test if instructed.

What the Test Results Mean

Results show the levels of free kappa and lambda light chains. Elevated levels can indicate conditions like multiple myeloma, where abnormal plasma cells produce too many light chains. Your provider will interpret the results in the context of your symptoms and medical history.

Common Conditions Monitored

This test is often used to diagnose or monitor multiple myeloma, a cancer of plasma cells, or other conditions such as monoclonal gammopathy of undetermined significance (MGUS) and Waldenström macroglobulinemia.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Abnormally high levels of free light chains can signal plasma cell disorders. For example, multiple myeloma often shows an imbalance between kappa and lambda chains. Your provider will use these results alongside other tests and clinical findings to guide diagnosis and treatment planning.

Short name

Free Light Chain Test

Frequently asked questions

What causes abnormal light chain levels?
Abnormal light chain levels are most commonly associated with plasma cell disorders, such as multiple myeloma, where plasma cells produce too many light chains. Other conditions like MGUS or certain infections may also cause temporary changes.
How often will I need this test?
The frequency depends on your medical condition. If you have a known plasma cell disorder, your provider may recommend regular testing to monitor disease progression or treatment effectiveness.
Can diet or medications affect this test?
Dietary changes or certain medications may indirectly affect blood protein levels, but they typically do not directly influence light chain measurements. Follow your provider’s instructions regarding fasting or other preparations.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy